A Phase 2, Open-Label, Single-Arm, Multidose Study to Investigate the Effects of Orteronel on the QT/QTc Interval in Patients With Metastatic Castration-Resistant Prostate Cancer
Phase of Trial: Phase II
Latest Information Update: 09 Jun 2016
At a glance
- Drugs Orteronel (Primary) ; Prednisone
- Indications Prostate cancer
- Focus Adverse reactions
- Sponsors Millennium
- 01 Mar 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Jan 2013 Planned End Date changed from 1 Dec 2014 to 1 Sep 2014 as reported by ClinicalTrials.gov.
- 23 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.